Literature DB >> 18154556

Contact sensitivity in patients with venous leg ulcers in Serbia: comparison with contact dermatitis patients and relationship to ulcer duration.

Jasmina Jankićević1, Sonja Vesić, Jelica Vukićević, Miodrag Gajić, Metka Adamic, Milos D Pavlović.   

Abstract

BACKGROUND: Contact hypersensitivity is a common occurrence in patients with chronic venous leg ulcers (CVLU) with allergen profiles depending upon the local treatment policies.
OBJECTIVE: This study was to determine the frequency of contact sensitivity, prevalence of individual allergens, polyvalent sensitization, and/or their relationship to ulcers duration in the population of CVLU and contact dermatitis patients in Serbia. PATIENTS: 75 patients with CVLU and 82 patients with clinically suspected contact dermatitis were prospectively included in the study. The patients were patch tested with a series of 21 standard and 22 supplemental allergens.
RESULTS: 73% (n = 55) of CVLU and 52% (n = 43) of control subjects had 1 or more positive patch test results (P < 0.01). Polysensitization was found in 53% of patients and 21% of controls (P < 0.01). CVLU patients run 2.5 and 4.3 higher risk for contact sensitization and polysensitization, respectively. The most common allergens were Balsam of Peru (21.3%), carba mix (18.7%), fusidic acid (17.3%), colophony (13.3%), paraben mix (12%), chloramphenicol (12%), silver nitrate (12%), and neomycin (10.7%). Polivalent sensitization and higher mean number of allergens were associated with ulcer duration >5 years.
CONCLUSIONS: The results confirm a high rate of contact (poly)sensitization in patients with CVLU and local variability in allergen prevalence.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18154556     DOI: 10.1111/j.1600-0536.2007.01253.x

Source DB:  PubMed          Journal:  Contact Dermatitis        ISSN: 0105-1873            Impact factor:   6.600


  8 in total

1.  Moisturizer allergy: diagnosis and management.

Authors:  Matthew J Zirwas; Sarah A Stechschulte
Journal:  J Clin Aesthet Dermatol       Date:  2008-11

2.  [Patch testing in patients with leg ulcers with special regard to modern wound products].

Authors:  S Reich-Schupke; J Kurscheidt; C Appelhans; A Kreuter; P Altmeyer; M Stücker
Journal:  Hautarzt       Date:  2010-07       Impact factor: 0.751

3.  Prevalence and trend of allergen sensitization in patients with a diagnosis of stasis dermatitis referred for patch testing, North American contact dermatitis group data, 2001-2016.

Authors:  Jonathan I Silverberg; Alexander Hou; Erin M Warshaw; Howard I Maibach; Donald V Belsito; Joel G DeKoven; Kathryn A Zug; James S Taylor; Denis Sasseville; Anthony F Fransway; Vincent A DeLeo; Melanie D Pratt; Margo J Reeder; Amber R Atwater; Joseph F Fowler; Matthew J Zirwas; James G Marks
Journal:  Arch Dermatol Res       Date:  2021-11-08       Impact factor: 3.033

4.  Treatment of xerosis with a topical formulation containing glyceryl glucoside, natural moisturizing factors, and ceramide.

Authors:  Teresa M Weber; Martina Kausch; Frank Rippke; Andrea M Schoelermann; Alexander W Filbry
Journal:  J Clin Aesthet Dermatol       Date:  2012-08

5.  Contact sensitivity in patients with venous leg ulcer: A multi-centric Indian study.

Authors:  Reena Rai; Manjunath M Shenoy; Vishalakshi Viswanath; Nilendu Sarma; Imran Majid; Sunil Dogra
Journal:  Int Wound J       Date:  2018-03-30       Impact factor: 3.315

6.  Hypersensitivity reactions to non beta-lactam antimicrobial agents, a statement of the WAO special committee on drug allergy.

Authors:  Mario Sánchez-Borges; Bernard Thong; Miguel Blanca; Luis Felipe Chiaverini Ensina; Sandra González-Díaz; Paul A Greenberger; Edgardo Jares; Young-Koo Jee; Luciana Kase-Tanno; David Khan; Jung-Won Park; Werner Pichler; Antonino Romano; Maria José Torres Jaén
Journal:  World Allergy Organ J       Date:  2013-10-31       Impact factor: 4.084

7.  Synergistic effect of haloduracin and chloramphenicol against clinically important Gram-positive bacteria.

Authors:  Abolghasem Danesh; Åsa Ljungh; Bo Mattiasson; Gashaw Mamo
Journal:  Biotechnol Rep (Amst)       Date:  2016-12-27

8.  Reaction or infection: topical chloramphenicol treatment.

Authors:  R J Livingston; J W Butterworth; P Belt
Journal:  Ann R Coll Surg Engl       Date:  2013-01       Impact factor: 1.951

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.